Investors interested in Automotive - Original Equipment stocks are likely familiar with Visteon (VC) and Ferrari (RACE). But which of these two stocks offers value investors a better bang for their buck right now?

Investors interested in Banks - Foreign stocks are likely familiar with Banco Santander (SAN) and Bank of Nova Scotia (BNS). But which of these two companies is the best option for those looking for undervalued stocks?

Investors with an interest in Building Products - Miscellaneous stocks have likely encountered both Compagnie de Saint-Gobain - Unsponsored ADR (CODYY) and TopBuild (BLD). But which of these two companies is the best option for those looking for undervalued stocks?

Investors with an interest in Computer - Peripheral Equipment stocks have likely encountered both LG Display (LPL) and Logitech (LOGI). But which of these two stocks presents investors with the better value opportunity right now?

Investors interested in stocks from the Diversified Communication Services sector have probably already heard of Telefonica Brasil (VIV) and Telus (TU). But which of these two stocks presents investors with the better value opportunity right now?

Investors looking for stocks in the Financial - Investment Management sector might want to consider either AllianceBernstein (AB) or BlackRock (BLK). But which of these two companies is the best option for those looking for undervalued stocks?

Investors looking for stocks in the Financial - Miscellaneous Services sector might want to consider either XP Inc.A (XP) or SoFi Technologies, Inc. (SOFI). But which of these two stocks presents investors with the better value opportunity right now?

Investors looking for stocks in the Manufacturing - General Industrial sector might want to consider either Regal Rexnord (RRX) or Trimble Navigation (TRMB). But which of these two companies is the best option for those looking for undervalued stocks?

Investors interested in Medical - Products stocks are likely familiar with Smith & Nephew (SNN) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Keros Therapeutics, Inc. (KROS) and Exact Sciences (EXAS). But which of these two stocks is more attractive to value investors?

Investors looking for stocks in the Electronics - Semiconductors sector might want to consider either United Microelectronics Corporation (UMC) or Nova Ltd. (NVMI). But which of these two stocks is more attractive to value investors?

Investors with an interest in Medical - Drugs stocks have likely encountered both Catalyst Pharmaceutical (CPRX) and Neurocrine Biosciences (NBIX). But which of these two companies is the best option for those looking for undervalued stocks?

Carlsbad, CA, July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("Qualigen" or the "Company"), a life sciences company focused on developing platform treatments for adult and pediatric cancers with the potential for orphan drug designations, today announced that it has entered into definitive securities purchase agreements with several institutional and accredited investors for the sale of its Series A-3 Preferred Stock. The private placement closed on July 28, 2025. The Company issued and sold an aggregate of 4,500 shares of Series A-3 Preferred Stock, with a stated value of $1,000 per share, for aggregate gross proceeds of $4.5 …

Apple Inc (NASDAQ:AAPL, ETR:APC) is expected to deliver a revenue and earnings beat when it reports its fiscal third quarter earnings this week, analysts at Goldman Sachs believe. The analysts maintain a ‘Buy' rating on the iPhone maker but slightly lowered their price target to $251 from $253.

ATLANTA, July 28, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against PepGen Inc. (“PepGen” or the “Company”) (NASDAQ: PEPG). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information about PepGen's business, operations, and prospects, including allegations that: (i) PGN-EDO51 was less effective and safe than Defendants had led investors to believe; (ii) the CONNECT2 study was deficient for purposes of U.S. Food and Drug Administration (“FDA”) approval; and (iii) as a result of all the foregoing, PepGen was likely to halt the CONNECT2 study, and PGN-EDO51's …

Despite a broader industry downturn that saw its revenues decline sharply, Axcelis Technologies, Inc. is expanding its gross, operating, and free cash flow margins while maintaining a robust balance sheet. Recent data indicates that the semiconductor industry is heading to a cyclical rebound later this year, potentially setting Axcelis up for a return to revenue growth. Axcelis' ion implanters are specialized in wide band-gap materials, allowing it to capitalize on the growing adoption for SiC and GaN semiconductors.

HUM's second-quarter earnings are likely to have witnessed strength in insurance premiums and Medicare, partly offset by rising costs and membership declines.

SPY's five-day record streak has powered high-beta and momentum ETFs like SPMO, SPHB, MTUM and JMOM.

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Edgewise Therapeutics, Inc. (“Edgewise” or the “Company”) (NASDAQ: EWTX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Toronto, Ontario--(Newsfile Corp. - July 28, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in junior resource and venture stocks, shares exclusive updates with CEOs of junior mining explorers. Founded in 2012, CEO.CA, a wholly owned subsidiary of EarthLabs, Inc. , is one of the most popular free financial websites and apps in Canada and for investors globally - with industry leading audience engagement and mobile functionality.